rxstat › Shortages › Buspirone

Buspirone shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Buspirone is in a widespread shortage in Canada. 5 of 8 reported products are affected. The latest manufacturer estimate for full recovery is Aug 3, 2026.
Products affected
5 of 8
In shortage since
Jan 23, 2024
Est. full return
Aug 3, 2026
Reports on file
24
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
AMB-BUSPIRONE
10MG · TABLET · AMBICARE PHARMACEUTICALS INC.
DIN 02550555 · since May 28, 2026, est. end Jul 6, 2026 · Demand increase for the drug.
Active shortage
PMS-BUSPIRONE
10MG · TABLET · PHARMASCIENCE INC
DIN 02230942 · since Jun 17, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
AURO-BUSPIRONE
10MG · TABLET · AURO PHARMA INC
DIN 02500213 · since May 28, 2026, est. end Aug 3, 2026 · Delay in shipping of the drug.
Active shortage
BUSPIRONE
10MG · TABLET · SANIS HEALTH INC
DIN 02447851 · since Dec 17, 2025, no end estimate · Other (Please describe in comments)
Active shortage
APO-BUSPIRONE
10MG · TABLET · APOTEX INC
DIN 02211076 · since Jan 23, 2024, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-BUSPIRONE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02231492
Resolved
TEVA-BUSPIRONE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02231492 · ended May 5, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUSPIRONE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02231492 · ended Nov 1, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUSPIRONE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02231492 · ended Mar 12, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP BUSPIRONE
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02509911 · ended Jan 21, 2025 · Demand increase for the drug.
Resolved
PRO-BUSPIRONE
10MG · TABLET · PRO DOC LIMITEE
DIN 02223163 · ended Oct 23, 2024 · Delay in shipping of the drug.
Resolved
AURO-BUSPIRONE
10MG · TABLET · AURO PHARMA INC
DIN 02500213 · ended Mar 27, 2024 · Demand increase for the drug.

Showing 12 of 24 reports. All reports are on file with Health Canada.

What's happening

Buspirone is currently affected by 5 active shortage reports filed with Health Canada by AMBICARE PHARMACEUTICALS INC., PHARMASCIENCE INC, AURO PHARMA INC, SANIS HEALTH INC and 1 others.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug; delay in shipping of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Buspirone is classified under “ANXIOLYTICS” (ATC N05BE).

Recent changes

Common questions

When will Buspirone be back in stock in Canada?

The latest manufacturer estimate is Aug 3, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Buspirone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (anxiolytics)

Widespread shortageChlordiazepoxide2 of 3 reported products affectedWidespread shortageOxazepam6 of 10 reported products affectedPartial shortageAlprazolam4 of 20 reported products affected · est. return Jul 3, 2026Partial shortageDiazepam4 of 18 reported products affectedPartial shortageHydroxyzine2 of 8 reported products affectedPartial shortageLorazepam1 of 27 reported products affected · est. return May 1, 2026

All anxiolytics shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.